These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9869334)

  • 1. Lu 25-109, a combined m1 agonist and m2 antagonist, modulates regulated processing of the amyloid precursor protein of Alzheimer's disease.
    Müller D; Wiegmann H; Langer U; Moltzen-Lenz S; Nitsch RM
    J Neural Transm (Vienna); 1998; 105(8-9):1029-43. PubMed ID: 9869334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells.
    DeLapp N; Wu S; Belagaje R; Johnstone E; Little S; Shannon H; Bymaster F; Calligaro D; Mitch C; Whitesitt C; Ward J; Sheardown M; Fink-Jensen A; Jeppesen L; Thomsen C; Sauerberg P
    Biochem Biophys Res Commun; 1998 Mar; 244(1):156-60. PubMed ID: 9514902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain.
    Müller DM; Mendla K; Farber SA; Nitsch RM
    Life Sci; 1997; 60(13-14):985-91. PubMed ID: 9121365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6beta-acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain.
    Qiu Y; Chen HZ; Wu XJ; Jin ZJ
    Eur J Pharmacol; 2003 May; 468(1):1-8. PubMed ID: 12729836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro.
    Sánchez C; Arnt J; Didriksen M; Dragsted N; Moltzen Lenz S; Matz J
    Psychopharmacology (Berl); 1998 Jun; 137(3):233-40. PubMed ID: 9683000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
    Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
    J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
    Seo H; Ferree AW; Isacson O
    Eur J Neurosci; 2002 Feb; 15(3):498-506. PubMed ID: 11876777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous changes in secretory amyloid precursor protein and beta-amyloid peptide release from rat hippocampus by activation of muscarinic receptors.
    Qiu Y; Wu XJ; Chen HZ
    Neurosci Lett; 2003 Nov; 352(1):41-4. PubMed ID: 14615045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from Chinese hamster ovary-m1 cells.
    Eckols K; Bymaster FP; Mitch CH; Shannon HE; Ward JS; DeLapp NW
    Life Sci; 1995; 57(12):1183-90. PubMed ID: 7674807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated secretion of beta-amyloid precursor protein in rat brain.
    Farber SA; Nitsch RM; Schulz JG; Wurtman RJ
    J Neurosci; 1995 Nov; 15(11):7442-51. PubMed ID: 7472496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices.
    Nitsch RM; Slack BE; Farber SA; Schulz JG; Deng M; Kim C; Borghesani PR; Korver W; Wurtman RJ; Growdon JH
    J Neural Transm Suppl; 1994; 44():21-7. PubMed ID: 7897393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease.
    Nitsch RM; Wurtman RJ; Growdon JH
    Arzneimittelforschung; 1995 Mar; 45(3A):435-8. PubMed ID: 7763340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells.
    Danenberg HD; Haring R; Heldman E; Gurwitz D; Ben-Nathan D; Pittel Z; Zuckerman A; Fisher A
    Ann N Y Acad Sci; 1995 Dec; 774():300-3. PubMed ID: 8597471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-coupled amyloid precursor protein processing.
    Nitsch RM; Slack BE; Farber SA; Borghesani PR; Schulz JG; Kim C; Felder CC; Growdon JH; Wurtman RJ
    Ann N Y Acad Sci; 1993 Sep; 695():122-7. PubMed ID: 8239269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.
    Nitsch RM; Slack BE; Wurtman RJ; Growdon JH
    Science; 1992 Oct; 258(5080):304-7. PubMed ID: 1411529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease. Rationale and perspectives.
    Fisher A; Michaelson DM; Brandeis R; Haring R; Chapman S; Pittel Z
    Ann N Y Acad Sci; 2000; 920():315-20. PubMed ID: 11193170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.
    Fisher A; Brandeis R; Haring R; Eshhar N; Heldman E; Karton Y; Eisenberg O; Meshulam H; Marciano D; Bar-Ner N; Pittel Z
    J Physiol Paris; 1998; 92(5-6):337-40. PubMed ID: 9789833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T; Perez-Polo JR; Schliebs R
    J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion.
    Nitsch RM; Deng M; Growdon JH; Wurtman RJ
    J Biol Chem; 1996 Feb; 271(8):4188-94. PubMed ID: 8626761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.